GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GI Innovation Inc (XKRX:358570) » Definitions » Margin of Safety % (DCF Earnings Based)

GI Innovation (XKRX:358570) Margin of Safety % (DCF Earnings Based) : N/A (As of Apr. 30, 2025)


View and export this data going back to 2023. Start your Free Trial

What is GI Innovation Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

GI Innovation's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


Competitive Comparison of GI Innovation's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, GI Innovation's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GI Innovation's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GI Innovation's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where GI Innovation's Margin of Safety % (DCF Earnings Based) falls into.


;
;

GI Innovation Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of GI Innovation's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


GI Innovation Business Description

Industry
Traded in Other Exchanges
N/A
Address
Songpa-daero 167, Room 1116 of A-dong, Songpa-gu, Seoul, KOR, 05855
GI Innovation Inc is a bio-venture company that researches and develops protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART platform.

GI Innovation Headlines

No Headlines